about
Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum.A novel scalable manufacturing process for the production of hydrogel-forming microneedle arrays.A facile system to evaluate in vitro drug release from dissolving microneedle arrays.Transdermal Delivery of Iron Using Soluble Microneedles: Dermal Kinetics and SafetyThe Use of a Pressure-Indicating Sensor Film to Provide Feedback upon Hydrogel-Forming Microneedle Array Self-Application In Vivo.Transdermal Drug Delivery Mediated by Microneedle Arrays: Innovations and Barriers to Success.In vivo and qualitative studies investigating the translational potential of microneedles for use in the older population.DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles.Transcending epithelial and intracellular biological barriers; a prototype DNA delivery device.Using debate to teach pharmacy students about ethical issues.Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery.Design of a Dissolving Microneedle Platform for Transdermal Delivery of a Fixed-Dose Combination of Cardiovascular Drugs.Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis.Methylene Blue-Loaded Dissolving Microneedles: Potential Use in Photodynamic Antimicrobial Chemotherapy of Infected WoundsParents' perceptions of microneedle-mediated monitoring as an alternative to blood sampling in the monitoring of their infants.Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine Langerhans cells.Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet.Patient safety and beyond: what should we expect from microneedle arrays in the transdermal delivery arena?Potential of hydrogel-forming and dissolving microneedles for use in paediatric populations.Hydrogels for Hydrophobic Drug Delivery. Classification, Synthesis and Applications.Microneedles as the technique of drug delivery enhancement in diverse organs and tissues.DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle system.How can microneedles overcome challenges facing transdermal drug delivery?A Novel Transdermal Protein Delivery Strategy via Electrohydrodynamic Coating of PLGA Microparticles onto MicroneedlesPotential of Polymeric Films Loaded with Gold Nanorods for Local Hyperthermia ApplicationsNovel nanosuspension-based dissolving microneedle arrays for transdermal delivery of a hydrophobic drugHow innovative drug delivery devices can help realize clinical utility of new effective therapiesDesign and Development of Liquid Drug Reservoirs for Microneedle Delivery of Poorly Soluble Drug MoleculesEnhancement in Site-Specific Delivery of Carvacrol against Methicillin Resistant Staphylococcus aureus Induced Skin Infections Using Enzyme Responsive Nanoparticles: A Proof of Concept StudyNanosuspension-Based Dissolving Microneedle Arrays for Intradermal Delivery of CurcuminInfluence of molecular weight on transdermal delivery of model macromolecules using hydrogel-forming microneedles: potential to enhance the administration of novel low molecular weight biotherapeuticsDesign, Formulation, and Evaluation of Novel Dissolving Microarray Patches Containing Rilpivirine for Intravaginal DeliveryNovel Hydrogel-Forming Microneedle Array for Intradermal Vaccination in Mice Using Ovalbumin as a Model Protein AntigenCelecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedurePhotosensitiser delivery for photodynamic therapy. Part 1: Topical carrier platformsPrefacePlasmonic photothermal microneedle arrays and single needles for minimally-invasive deep in-skin hyperthermiaNovel Design Approaches in the Fabrication of Polymeric Microarray Patches via MicromouldingMicroneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations
P50
Q26778469-0B588CB2-0792-42B5-8E9D-F2380EF22E40Q36181678-123A07AB-9DBC-4D1F-9987-A09E02C543C5Q36490572-BD5C73D7-E470-4C55-83E8-A7D5DA142392Q36638726-FEC5850C-DC4F-42BA-9B40-0507EDFD3285Q37389669-7BB13691-2C8A-4792-AA6A-04C87F67251FQ38671264-7D01BD05-A16C-4361-99EC-80B93201FDA3Q38683388-9BB0C917-FCAA-49FC-896C-7A9AA8F6E518Q38726068-D3A70B4F-DA55-4B1D-8811-E7CFFE3956BAQ38793709-57B9C79B-476F-4690-B6E2-D111D6BF807AQ38910206-EE84D0AE-5C1E-414E-901D-AAF484B16AA4Q38978014-3A588E7E-8388-443A-B21B-5B2EDECF73A7Q38987704-FA8C8064-DE1D-4B8F-A847-8EF047C81892Q40115092-16845B1C-C568-4F01-BCF1-F03D857310F3Q40971257-7B707608-072A-43A7-87C8-7F5A0D74ED9EQ41162101-674A65C6-B735-4D14-B2B8-DCE8AD85C86AQ41613756-F8FDE4B8-3EEB-46E5-BD7B-8FC6B9C3E5CDQ41730559-48A0D4C8-A966-432F-A885-3B0B82187E4FQ44542292-4BD4A477-E34D-410D-8B28-F165ACD8CCF4Q45204909-8F0D0B6D-B04E-44FD-966C-4BC7E843E03BQ47710187-0C0B580E-C78C-45DD-BAAD-B1537C72DBBEQ48174596-9EACC698-937B-4C0F-AC0B-3A82EC62E063Q50083678-CEEB0D4C-D410-4B91-A02F-F36745ED6723Q52671648-85CEB79D-F38E-4C0B-B59E-015EBCF2C579Q53779557-D5387EAF-22DE-431F-AE2D-8D1387D61C9CQ89745526-243B676F-FAD1-45C8-8176-C405135F50A5Q90632394-D3D24463-3B10-40E4-A959-D4776BA3EC77Q90701306-D77B18BC-0907-4061-B67F-26FF82DDC2B8Q91148489-6560AB63-FCEE-46F7-A1AE-1C1F73A3CCF6Q91442660-27C64366-4996-4936-995B-9F1DB29E3D08Q91443144-AFCF5E7C-4BD3-4BF1-AE15-F01F278FAF50Q91587476-8D87E9A0-3496-41E1-A5C9-5BB5D342942EQ91946815-F266EECA-819F-4A45-92F0-03A1501BBB86Q92154935-F88BCE8A-0D0F-447D-B5A8-48E23F12AD99Q93212583-56F90789-BF7D-4D92-A8AD-FDD9815F8302Q94494808-41BBDA0C-A5CB-49CD-9444-0F1C751C2224Q94702849-C17CAF89-7539-4652-8F79-9D1DACCB2BF3Q95458975-607B7EC2-A604-4100-9FF7-4E9C1C23E12FQ96112338-353E1BF9-1107-48F4-A524-7D5F88CC8D8FQ96115997-DBC9E316-AF5F-43B7-9F03-92BF93BB0A4FQ96130508-A53ECCFC-D441-4754-A3AF-F3665AFC2E3E
P50
description
researcher
@en
name
Ryan F Donnelly
@en
type
label
Ryan F Donnelly
@en
prefLabel
Ryan F Donnelly
@en
P31
P496
0000-0002-0766-4147